Nexstim's NBS System 6 received FDA clearance for adjunctive treatment of adult OCD in the U.S.; the navigated E-field TMS system remains cleared for MDD and pre-surgical mapping and emphasizes MRI-based individualized targeting and a modular, software-guided workflow.
Read moreResonetics acquires Resolution Medical to expand integrated design, battery, and manufacturing capabilities for neuromodulation and interventional medical de...
Read moreMave Health raised $2.1M to launch a tDCS wearable for stress, focus and brain health in the US and India; shipping starts April 2026.
Read moreMeta awards six universities $150K each to study wrist sEMG for speech, accessibility, training, privacy, and higher-bandwidth wearable input.
Read more